华特达因: 关于持股5%以上股东增持公司股份达到3.7%暨增持计划完成的公告

Core Viewpoint - The major shareholder, Guo Weisong, has completed a share buyback plan, increasing his stake in Huate Dain Health Co., Ltd. to 3.7% of the total share capital, reflecting confidence in the company's future prospects [1][3]. Summary by Sections Shareholding Increase - Guo Weisong acquired 8,660,000 shares from June 30 to July 1, 2025, which represents 3.7% of the company's total share capital [1][3]. - Prior to this increase, Guo Weisong held 14,060,024 shares, accounting for 6.0% of the total share capital [2][3]. Buyback Plan Details - The buyback plan initiated by Guo Weisong aimed to purchase between 4.33 million shares (1.85%) and 8.66 million shares (3.70%) within a six-month period starting June 26, 2025 [2][3]. - The funding for this buyback was sourced from Guo Weisong's own funds, with no price range set for the purchases [2][3]. Compliance and Governance - The increase in shareholding does not alter the company's control structure or governance, as Guo Weisong is not seeking to gain actual control over the company [3][4]. - The buyback plan aligns with previously disclosed commitments and does not violate any relevant laws or regulations [3][4].